Literature DB >> 18770366

Lymphoproliferative disease of turkeys. II. Experimental transmission and aetiology.

J S McDougall1, P M Biggs, R W Shilleto, B S Milne.   

Abstract

The clinical and pathological features of a previously reported lympho-proliferative disease of turkeys were reproduced by inoculation of 4-week-old poults, and spread to in contact turkeys was demonstrated. From studies on the development of the lesions in inoculated turkeys, it was possible to assay the causative agent based on microscopic examination of early lesions. Poults were more susceptible to inoculation when 4 weeks old than to inoculation at 1 day old, and different strains of turkey varied in their susceptibility to inoculation. The causative agent did not appear to be antigenically related to avian leukosis virus, to Marek's disease virus or to reticuloendotheliosis virus. Preliminary characterisation studies indicated a virus with properties similar to those of oncoviruses.

Entities:  

Year:  1978        PMID: 18770366     DOI: 10.1080/03079457808418266

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  3 in total

1.  Avian oncogenesis induced by lymphoproliferative disease virus: a neglected or emerging retroviral pathogen?

Authors:  Andrew B Allison; M Kevin Keel; Jamie E Philips; Andrew N Cartoceti; Brandon A Munk; Nicole M Nemeth; Trista I Welsh; Jesse M Thomas; James M Crum; Anne B Lichtenwalner; Aly M Fadly; Guillermo Zavala; Edward C Holmes; Justin D Brown
Journal:  Virology       Date:  2013-12-18       Impact factor: 3.616

2.  Characterisation of lymphoproliferative disease virus of turkeys. Structural polypeptides of the C-type particles.

Authors:  J R Patel; R W Shilleto
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Molecular Surveillance for Lymphoproliferative Disease Virus in Wild Turkeys (Meleagris gallopavo) from the Eastern United States.

Authors:  Jesse M Thomas; Andrew B Allison; Edward C Holmes; Jamie E Phillips; Elizabeth M Bunting; Michael J Yabsley; Justin D Brown
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.